A recent publication reported that tumor IFN-γ receptor1 signaling was required for CAR T cell killing efficacy in glioblastoma cells through regulating cell adhesion in CAR T-tumor cell interactions, in which the CAR T cell-induced but tumor-produced ICAM-1 played a critical role (23). Here, ICAM1 is linked to neoplasm.